Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Merrimack Pharmaceuticals Inc. buy DERFY

Merrimack Pharmaceuticals Inc.
Start price
€26.20
24.01.17 / 50%
Target price
€73.87
24.07.17
Performance (%)
-19.02%
End price
€11.70
24.07.17
Summary
This prediction ended on 24.07.17 with a price of €11.70. The prediction for Merrimack Pharmaceuticals Inc. disappointed with a performance of -19.02%. DERFY has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Merrimack Pharmaceuticals Inc. - - - -
iShares Core DAX® -0.046% 5.960% 7.403% 65.851%
iShares Nasdaq 100 0.922% 3.693% 28.138% 93.298%
iShares Nikkei 225® 3.014% 6.638% 48.886% 89.079%
iShares S&P 500 -0.359% 2.747% 22.530% 71.942%

Comments by DERFY for this prediction

In the thread Merrimack Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -19.02%
Target price 73.874
Change
Ends at 24.07.17

DERFY stimmt dem Sentiment von 'Buy' zu

DERFY stimmt am 24.01.2017 dem Buy-Gesamtsentiment mit dem Kursziel 8.19$ zu.

DERFY 
0
Report Share
24.01.17
Prediction Buy
Perf. (%) -19.02%
Target price 73.874
Change
Ends at 24.07.17

(Laufzeit überschritten)

DERFY 
0
Report Share
24.07.17